Status:
TERMINATED
iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications
Lead Sponsor:
Glaukos Corporation
Conditions:
Primary Open Angle Glaucoma (POAG)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medication...
Detailed Description
The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medication...
Eligibility Criteria
Inclusion
- Diagnosed with primary open angle glaucoma (POAG)
- Subject on two ocular hypotensive medications
Exclusion
- Traumatic, uveitic, neovascular, or angle closure glaucoma
- Fellow eye already enrolled
Key Trial Info
Start Date :
February 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03478293
Start Date
February 27 2018
End Date
December 30 2020
Last Update
September 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology - UNIFESP/ Hospital São Paulo
São Paulo, Brazil, 04023-62